Ethical Considerations of Cosmetic GLP-1 Receptor Agonist Prescribing in Dermatology

By afschroeder • September 9, 2026

Jonnalagadda A, Lowry WP, Pathak GN, Choi E, Zhou AE, Grant-Kels JM. Ethical Considerations of Cosmetic GLP-1 Receptor Agonist Prescribing in Dermatology. Clin Dermatol. 2026 Sep 8:S0738-081X(26)00228-2. doi: 10.1016/j.clindermatol.2026.09.002. Epub ahead of print. PMID: 42710721.

Tags: clinical trials, conflicts of interest, Dermatology, dermatology, drug development, ethics, FDA approval, Fellow, industry relationships, material nonpublic information, patient trust, physician professionalism, prediction markets, Publications, research integrity

Trends in MD-PhD representation and match outcomes across competitive specialties, 2007-2024

Zhou AE, Klufas T, Choi E, Kim YW, Kim JJ, Sarfo A, Sloan B, Feng H. Trends in MD-PhD representation and match outcomes across competitive[...]

Epidermotropic Metastatic Prostate Adenocarcinoma With Florid Squamous Transformation/Differentiation and Associated Acantholysis. An Unusual Clinicopathologic Entity

Hoffman SJ, Sadrolashrafi K, Mobini N. Epidermotropic Metastatic Prostate Adenocarcinoma With Florid Squamous Transformation/Differentiation and Associated Acantholysis. An Unusual Clinicopathologic Entity. Case Rep Dermatol Med.[...]

Prediction Markets in Dermatology: Ethical Considerations for Physicians

Jonnalagadda A, Desai AD, Zhou AE, Grant-Kels JM. Prediction Markets in Dermatology: Ethical Considerations for Physicians. Clin Dermatol. 2026 Sep 3:S0738-081X(26)00226-9. doi: 10.1016/j.clindermatol.2026.09.001. Epub ahead[...]